2022 CPHI Korea 

Discover your next small molecule drug product and get it to market faster, eliminating risks and meeting regulatory requirements in a fraction of the time. No one can afford to spend time developing a drug that won’t make it to market. Here we present a service tailored to help you find a large number of potential candidates and then select only the most promising for further development. 

The challenge

Knowledge is everything and in this fast-paced environment, drug discovery must be lean, targeted, dynamic and based on sound data analytics. But, with stretched resources, difficulties in deciphering multiparameter datasets and team members pulled in many directions, time slips away. 

This leads to project stagnation, a lack of data, a difficult decision-making process and ultimately late-stage failures. And the later they are, the more expensive they become. 

The solution

Malvern Panalytical’s contract drug discovery services, described in this session, combine:

• Powerful AI-driven drug identification and optimization technology.
• Medicinal, regulatory and industry experts for all therapeutic areas (from Immuno-Oncology to Neuroscience) that can work flexibly and as closely with your team as needed.
• A dedicated project management approach with a singular focus on getting your drug to market in the quickest way possible.

This presentation will elaborate on how the above approach speeds up the process of establishing a purposeful screening cascade, use enhanced analysis to accelerate development of the best candidates, and optimize leads to define the path to success.